{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:05Z","timestamp":1786991225001,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":3210,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.jacc.2004.05.084","type":"journal-article","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T11:19:00Z","timestamp":1097752740000},"page":"1557-1566","source":"Crossref","is-referenced-by-count":192,"title":["Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation"],"prefix":"10.1016","volume":"44","author":[{"given":"Francisco","family":"P\u00e9rez-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Alegr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Berj\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Iriarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Zumalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Mataix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2004.05.084_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2004.05.084_bib2","first-page":"1852","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation","volume":"22","author":"Fuster","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2004.05.084_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.05.084_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2004.05.084_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/01.CIR.84.2.469","article-title":"Nonrheumatic atrial fibrillation","volume":"84","author":"Cairns","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.05.084_bib6","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomised controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2004.05.084_bib7","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.05.084_bib8","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","article-title":"Fixed minidose warfarin and aspirin alone and in combination vs. adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study","volume":"158","author":"Gullov","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2004.05.084_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2796.2003.01159.x","article-title":"Effects of low dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation","volume":"254","author":"Edvardson","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2004.05.084_bib10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.084_bib11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00003495-199855060-00011","article-title":"Triflusal","volume":"55","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2004.05.084_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/euhj.1999.1874","article-title":"Randomised comparative trial of triflusal and aspirin following acute myocardial infarction","volume":"21","author":"Cruz-Fernandez","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2004.05.084_bib13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","article-title":"Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction","volume":"34","author":"Mat\u00edas-Guiu","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2004.05.084_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0895-4356(89)90066-8","article-title":"The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy","volume":"42","author":"Landefeld","year":"1989","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacc.2004.05.084_bib15","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.05.084_bib16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2004.05.084_bib17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.084_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199608223350802","article-title":"An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation","volume":"335","author":"Hylek","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.05.084_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jama.279.16.1273","article-title":"Patients with non-valvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study","volume":"279","year":"1998","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2004.05.084_bib20","first-page":"1","article-title":"A guide to oral anticoagulation treatment: recommendations of the Italian Federation of Anticoagulation Clinics (FCSA)","volume":"88","year":"2003","journal-title":"Haematologica\/J Hematol"},{"key":"10.1016\/j.jacc.2004.05.084_bib21","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","article-title":"Oral anticoagulants vs. aspirin in nonvalvular atrial fibrillation","volume":"288","author":"van Walraven","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2004.05.084_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-5223(19)40105-0","article-title":"Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves","volume":"72","author":"Altman","year":"1976","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2004.05.084_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2796.1994.tb00800.x","article-title":"Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients","volume":"236","author":"Hurlen","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacc.2004.05.084_bib24","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0002-9149(83)90673-2","article-title":"Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared to dipyridamole","volume":"51","author":"Chesebro","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2004.05.084_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00043798-199604000-00016","article-title":"Bleeding risk of combined oral anticoagulation and antiplatelet therapy in cardiovascular disease","volume":"3","author":"Verheugt","year":"1996","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.jacc.2004.05.084_bib26","doi-asserted-by":"crossref","DOI":"10.1378\/chest.114.5_Supplement.602S","article-title":"Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves","volume":"114","author":"Stein","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2004.05.084_bib27","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with oral direct thrombin inhibitor ximegalatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial","volume":"362","year":"2003","journal-title":"Lancet"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704015153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704015153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T06:32:28Z","timestamp":1585895548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109704015153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0735109704015153"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2004.05.084","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}